Log In
Print
BCIQ
Print
Print this Print this
 

Veltuzumab (hA20, IMMU-106)

  Manage Alerts
Collapse Summary General Information
Company Immunomedics Inc.
DescriptionHumanized anti-CD20 antibody
Molecular Target CD20
Mechanism of ActionAntibody
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today